6-Hydroxydopamine: a far from simple neurotoxin

被引：43
作者：
Vareslija, Damir [1 ,2 ]
Tipton, Keith F. [1 ]
Davey, Gavin P. [1 ]
McDonald, Andrew G. [1 ]
机构：
[1] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland
[2] Royal Coll Surgeons Ireland, Dept Surg, York House, York St, Dublin, Ireland
来源：
JOURNAL OF NEURAL TRANSMISSION | 2020年 / 127卷 / 02期
基金：
爱尔兰科学基金会;
关键词：
Neurotoxicity; Aminochrome; Apoptosis; Autoxidation; Dopamine; Highly reactive oxygen species (hROS); 4-Hydroxynonenal; Mitochondria; Iron release; Necrosis; Oxidative damage; Parkinson's disease; Peroxynitrite; Reactive oxygen species (ROS); NEURONAL CELL-DEATH; CATECHOL-O-METHYLTRANSFERASE; UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; MONOAMINE-OXIDASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; OXIDATIVE STRESS; COMPLEX-I;
D O I：
10.1007/s00702-019-02133-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
6-Hydroxydopamine (6-OHDA), which is a neurotoxin that selectively destroys catecholaminergic nerves in sympathetically innervated tissues, has been used to provide a model of Parkinson's disease in experimental animals. It is rapidly autoxidised to yield potentially toxic products and reactive oxygen species. Its ability to release Fe(II) from protein storage sites also results in the formation of hROS. This account will consider how this family of toxic products may contribute to the observed effects of 6-OHDA.
引用
收藏
页码：213 / 230
页数：18
相关论文
共 187 条
  • [41] ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE-METALS IN PARKINSONS-DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA
    DEXTER, DT
    CARAYON, A
    JAVOYAGID, F
    AGID, Y
    WELLS, FR
    DANIEL, SE
    LEES, AJ
    JENNER, P
    MARSDEN, CD
    [J]. BRAIN, 1991, 114 : 1953 - 1975
  • [42] Dimpfel W., 2011, BMC Pharmacology, V11, P2, DOI 10.1186/1471-2210-11-2
  • [43] Molecular Mechanisms That Differentiate Apoptosis from Programmed Necrosis
    Dorn, Gerald W., II
    [J]. TOXICOLOGIC PATHOLOGY, 2013, 41 (02) : 227 - 234
  • [44] 6-hydroxydopamine increases ubiquitin-conjugates and protein degradation: Implications for the pathogenesis of Parkinson's disease
    Elkon, H
    Melamed, E
    Offen, D
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2001, 21 (06) : 771 - 781
  • [45] TISSUE SULFHYDRYL GROUPS
    ELLMAN, GL
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) : 70 - 77
  • [46] Alpha-synuclein structure, functions, and interactions
    Emamzadeh, Fatemeh Nouri
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2016, 21 : 165 - 173
  • [47] Pharmacophore-Based discovery of substituted Pyridines as novel dopamine transporter inhibitors
    Enyedy, IJ
    Sakamuri, S
    Zaman, WA
    Johnson, KM
    Wang, SM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 513 - 517
  • [48] 6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum
    Ferger, B
    Rose, S
    Jenner, A
    Halliwell, B
    Jenner, P
    [J]. NEUROREPORT, 2001, 12 (06) : 1155 - 1159
  • [49] 6-Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo:: implication of peroxynitrite formation
    Ferger, B
    Themann, C
    Rose, S
    Halliwell, B
    Jenner, P
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 78 (03) : 509 - 514
  • [50] The physiopathological significance of ceruloplasmin - A possible therapeutic approach
    Floris, G
    Medda, R
    Padiglia, A
    Musci, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (12) : 1735 - 1741
12345678910